Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study

Background Data for front-line health-care workers and risk of COVID-19 are limited. We sought to assess risk of COVID-19 among front-line health-care workers compared with the general community and the effect of personal protective equipment (PPE) on risk. Methods We did a prospective, observational cohort study in the UK and the USA of the general community, including front-line health-care workers, using self-reported data from the COVID Symptom Study smartphone application (app) from March 24 (UK) and March 29 (USA) to April 23, 2020. Participants were voluntary users of the app and at first use provided information on demographic factors (including age, sex, race or ethnic background, height and weight, and occupation) and medical history, and subsequently reported any COVID-19 symptoms. We used Cox proportional hazards modelling to estimate multivariate-adjusted hazard ratios (HRs) of our primary outcome, which was a positive COVID-19 test. The COVID Symptom Study app is registered with ClinicalTrials.gov, NCT04331509. Findings Among 2 035 395 community individuals and 99 795 front-line health-care workers, we recorded 5545 incident reports of a positive COVID-19 test over 34 435 272 person-days. Compared with the general community, front-line health-care workers were at increased risk for reporting a positive COVID-19 test (adjusted HR 11·61, 95% CI 10·93–12·33). To account for differences in testing frequency between front-line health-care workers and the general community and possible selection bias, an inverse probability-weighted model was used to adjust for the likelihood of receiving a COVID-19 test (adjusted HR 3·40, 95% CI 3·37–3·43). Secondary and post-hoc analyses suggested adequacy of PPE, clinical setting, and ethnic background were also important factors. Interpretation In the UK and the USA, risk of reporting a positive test for COVID-19 was increased among front-line health-care workers. Health-care systems should ensure adequate availability of PPE and develop additional strategies to protect health-care workers from COVID-19, particularly those from Black, Asian, and minority ethnic backgrounds. Additional follow-up of these observational findings is needed. Funding Zoe Global, Wellcome Trust, Engineering and Physical Sciences Research Council, National Institutes of Health Research, UK Research and Innovation, Alzheimer's Society, National Institutes of Health, National Institute for Occupational Safety and Health, and Massachusetts Consortium on Pathogen Readiness.

[1]  Benjamin Silk,et al.  Characteristics of Health Care Personnel with COVID-19 — United States, February 12–April 9, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[2]  T. Spector,et al.  Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study , 2020, medRxiv : the preprint server for health sciences.

[3]  J. Moon,et al.  COVID-19: PCR screening of asymptomatic health-care workers at London hospital , 2020, The Lancet.

[4]  A. Kelso,et al.  Pandemic (H1N1) 2009 Risk for Frontline Health Care Workers , 2011, Emerging infectious diseases.

[5]  S. Selph,et al.  Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers , 2020, Annals of Internal Medicine.

[6]  Dylan H. Morris,et al.  Assessment of N95 respirator decontamination and re-use for SARS-CoV-2 , 2020, medRxiv.

[7]  T. Lancet,et al.  COVID-19: protecting health-care workers , 2020, The Lancet.

[8]  M. Jorge Cardoso,et al.  Rapid implementation of mobile technology for real-time epidemiology of COVID-19 , 2020, Science.

[9]  M. Edmond,et al.  Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. , 2016, The Cochrane database of systematic reviews.

[10]  G. Putoto,et al.  COVID-19 in Italy: momentous decisions and many uncertainties , 2020, The Lancet Global Health.

[11]  T. Burki Global shortage of personal protective equipment , 2020, The Lancet Infectious Diseases.

[12]  Charles Swanton,et al.  COVID-19: the case for health-care worker screening to prevent hospital transmission , 2020, The Lancet.

[13]  J. Peiris,et al.  Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS) , 2003, The Lancet.

[14]  Tze Wai Wong,et al.  SARS Transmission among Hospital Workers in Hong Kong , 2004, Emerging infectious diseases.

[15]  Lynnette Brammer,et al.  Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[16]  Edward Livingston,et al.  Sourcing Personal Protective Equipment During the COVID-19 Pandemic. , 2020, JAMA.

[17]  A. Berger FUNDAMENTALS OF BIOSTATISTICS , 1969 .

[18]  The Lancet COVID-19: protecting health-care workers , 2020, The Lancet.

[19]  A. Cook,et al.  Risk Factors for Pandemic (H1N1) 2009 Virus Seroconversion among Hospital Staff, Singapore , 2010, Emerging infectious diseases.

[20]  J. Brownstein,et al.  Putting the Public Back in Public Health - Surveying Symptoms of Covid-19. , 2020, The New England journal of medicine.

[21]  Tony Kirby,et al.  Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities , 2020, The Lancet Respiratory Medicine.

[22]  D. Koh,et al.  SARS: health care work can be hazardous to health , 2003, Occupational medicine.

[23]  G. Anderson,et al.  PPE Supply Chain Needs Data Transparency and Stress Testing , 2020, Journal of General Internal Medicine.

[24]  Tai Hing Lam,et al.  Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity , 2020, The Lancet.

[25]  Bernard R. Rosner,et al.  Fundamentals of Biostatistics. , 1992 .

[26]  John P. Thomas,et al.  Evaluating the national PPE guidance for NHS healthcare workers during the COVID-19 pandemic. , 2020, Clinical medicine.

[27]  Dylan H. Morris Assessment of N95 respirator decontamination and re-use for SARS-CoV-2 , 2020 .

[28]  J. A. Burch,et al.  Decontamination and Reuse of N95 Respirators with Hydrogen Peroxide Vapor to Address Worldwide Personal Protective Equipment Shortages During the SARS-CoV-2 (COVID-19) Pandemic , 2020, Applied biosafety : journal of the American Biological Safety Association.

[29]  David A. Drew,et al.  The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[30]  M. Baguelin,et al.  Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014–2016: A cross-sectional study , 2017, PLoS medicine.

[31]  Deepak L. Bhatt,et al.  Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers. , 2020, JAMA.

[32]  T. Hollingsworth,et al.  How will country-based mitigation measures influence the course of the COVID-19 epidemic? , 2020, The Lancet.

[33]  M. Jorge Cardoso,et al.  Real-time tracking of self-reported symptoms to predict potential COVID-19 , 2020, Nature Medicine.